Literature DB >> 23212430

Pharmacology of kratom: an emerging botanical agent with stimulant, analgesic and opioid-like effects.

Walter C Prozialeck1, Jateen K Jivan, Shridhar V Andurkar.   

Abstract

Kratom (Mitragyna speciosa) is a plant indigenous to Thailand and Southeast Asia. Kratom leaves produce complex stimulant and opioid-like analgesic effects. In Asia, kratom has been used to stave off fatigue and to manage pain, diarrhea, cough, and opioid withdrawal. Recently, kratom has become widely available in the United States and Europe by means of smoke shops and the Internet. Analyses of the medical literature and select Internet sites indicate that individuals in the United States are increasingly using kratom for the self-management of pain and opioid withdrawal. Kratom contains pharmacologically active constituents, most notably mitragynine and 7-hydroxymitragynine. Kratom is illegal in many countries. Although it is still legal in the United States, the US Drug Enforcement Administration has placed kratom on its "Drugs and Chemicals of Concern" list. Physicians should be aware of the availability, user habits, and health effects of kratom. Further research on the therapeutic uses, toxic effects, and abuse potential of kratom and its constituent compounds are needed.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23212430

Source DB:  PubMed          Journal:  J Am Osteopath Assoc        ISSN: 0098-6151


  56 in total

1.  The Right to Use Kratom from the Psychiatric and Islamic Perspectives.

Authors:  Mohammad Farris Iman Leong Bin Abdullah; Mohd Afifuddin Mohamad; Noor Naemah Abdul Rahman
Journal:  J Relig Health       Date:  2021-04

Review 2.  A Biased View of μ-Opioid Receptors?

Authors:  Alexandra E Conibear; Eamonn Kelly
Journal:  Mol Pharmacol       Date:  2019-06-07       Impact factor: 4.436

3.  Exploration of cytochrome P450 inhibition mediated drug-drug interaction potential of kratom alkaloids.

Authors:  Shyam H Kamble; Abhisheak Sharma; Tamara I King; Erin C Berthold; Francisco León; P Katharina L Meyer; Siva Rama Raju Kanumuri; Lance R McMahon; Christopher R McCurdy; Bonnie A Avery
Journal:  Toxicol Lett       Date:  2019-11-07       Impact factor: 4.372

Review 4.  The pharmacology and toxicology of kratom: from traditional herb to drug of abuse.

Authors:  Marcus L Warner; Nellie C Kaufman; Oliver Grundmann
Journal:  Int J Legal Med       Date:  2015-10-28       Impact factor: 2.686

5.  Novel case of maternal and neonatal kratom dependence and withdrawal.

Authors:  Lindsay Mackay; Ronald Abrahams
Journal:  Can Fam Physician       Date:  2018-02       Impact factor: 3.275

Review 6.  New directions in the treatment of opioid withdrawal.

Authors:  A Benjamin Srivastava; John J Mariani; Frances R Levin
Journal:  Lancet       Date:  2020-06-20       Impact factor: 79.321

7.  Metabolism of a Kratom Alkaloid Metabolite in Human Plasma Increases Its Opioid Potency and Efficacy.

Authors:  Shyam H Kamble; Francisco León; Tamara I King; Erin C Berthold; Carolina Lopera-Londoño; Kanumuri Siva Rama Raju; Aidan J Hampson; Abhisheak Sharma; Bonnie A Avery; Lance R McMahon; Christopher R McCurdy
Journal:  ACS Pharmacol Transl Sci       Date:  2020-07-31

8.  Fatal combination of mitragynine and quetiapine - a case report with discussion of a potential herb-drug interaction.

Authors:  Rhome L Hughes
Journal:  Forensic Sci Med Pathol       Date:  2018-11-29       Impact factor: 2.007

9.  Cardiac arrest in a young healthy male patient secondary to kratom ingestion: is this 'legal high' substance more dangerous than initially thought ?

Authors:  Hafez Mohammad Ammar Abdullah; Iqra Haq; Randall Lamfers
Journal:  BMJ Case Rep       Date:  2019-07-19

10.  Pentylenetetrazol-like stimulus is not produced following naloxone-precipitated mitragynine withdrawal in rats.

Authors:  Illa S Johari; Norsyifa Harun; Zarif M Sofian; Mohammed Shoaib
Journal:  Psychopharmacology (Berl)       Date:  2021-08-01       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.